Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 34.72
+0.23 (0.67%)
Last updated: Jul 17, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Nucleoside | 463.76M | Log In | Log In | Log In | Log In | Upgrade |
Nucleoside Growth | 22.71% | Log In | Log In | Log In | Log In | Upgrade |
Nucleotide | 146.23M | Log In | Log In | Log In | Log In | Upgrade |
Nucleotide Growth | -29.05% | Log In | Log In | Log In | Log In | Upgrade |
Purine | 146.03M | Log In | Log In | Log In | Log In | Upgrade |
Purine Growth | 17.16% | Log In | Log In | Log In | Log In | Upgrade |
Pyrimidine | 48.03M | Log In | Log In | Log In | Log In | Upgrade |
Pyrimidine Growth | -1.57% | Log In | Log In | Log In | Log In | Upgrade |
Other | 31.46M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 15.36% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
China | 751.94M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 7.56% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 83.57M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | -2.38% | Log In | Log In | Log In | Log In | Upgrade |
India | - | Log In | Log In | Log In | Log In | Upgrade |
India Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Italy | - | Log In | Log In | Log In | Log In | Upgrade |
Italy Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Indonesia | - | Log In | Log In | Log In | Log In | Upgrade |
Indonesia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Mexico | - | Log In | Log In | Log In | Log In | Upgrade |
Mexico Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Japan | - | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | - | Log In | Log In | Log In | Log In | Upgrade |